NEW YORK (GenomeWeb) – Australian molecular diagnostics firm Genetic Technologies announced today that it has partnered with Omix Ventures to develop and access a global genomic data management platform for cancer diagnostic development.
Omix Ventures is the parent organization of Project Shivom, which is developing a decentralized genomic data ecosystem called Global Genome ID based on blockchain — a technology for securely tracking and recording online transactions in a way that cannot be manipulated by any one entity.